65,437 trials
Lung Disease
Primary: Survival Without Bronchopulmonary Dysplasia (BPD) in Preterm Infants With Respiratory Distress — 258; 262 Participants — p=0.7340
Chronic Low Back Pain
Primary: Change From Baseline to 12 Weeks in Brief Pain Inventory 24-hour Average Pain Score — -2.48; -1.80 units on a scale — p=0.001
Diabetic Neuropathy, Painful
Primary: Mean Change From Baseline to 12 Weeks in Weekly Mean of Daily 24 Hour Average Pain Score, Pregabalin Compared With Duloxetine — -2.12; -2.62 units on a scale — p=0.076
Healthy Subjects Without Type 1 Diabetes
Primary: Overall Mean Sensor Glucose by Age Group — 98; 103; 97; 96 mg/dL — p=0.009
Vaccines, Pneumococcal Conjugate Vaccine
Primary: Percentage of Participants Achieving Serotype Specific IgG Antibody Concentration ≥0.35 Micrograms Per Milliliter (Mcg/mL) in the 13vPnC Group Relative to 7vPnC Group 1…
Mucopolysaccharidosis VI · Maroteaux-Lamy Syndrome
Primary: Change in Height — 67.3; 80.3; 81.9; 91.3 centimeters
Atrial Fibrillation · Cardiovascular Disease
Primary: First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke or Vascular Death as Per Adjudication — 963; 963; 136; 123 participants — p=0.8570
Myopia
Primary: Subjective Responses to Symptoms/Complaints — 80.0; 81.2 Visual Analogue Scale
Alcoholism · Alcohol Abuse · Alcohol Dependence
Primary: Change in Number of Heavy Drinking Days (i.e., 5 or More Drinks Per Day for Men, and 4 or More Per Day for Women)Per Week, by Week — -.30; -.20 Days/week — p=.012
Stroke
Primary: Change Between the Value of the SF-36 Physical Function Score at 12 Months Minus Value at Baseline to Measure the Change in Health-related Quality of Life and Function…
Fibrillation, Atrial
Primary: Number of Participants With Paroxysmal AF With an Event of Documented Symptomatic Atrial Fibrillation (AF)/Flutter — 129; 135; 140; 123 participants — p=0.263
Infection, Human Immunodeficiency Virus I · HIV Infection
Primary: Mean Change From Baseline in Estimated Glomerular Filtration Rate (GFR), Calculated by Modification of Diet in Renal Disease (MDRD) Equation, at Week 48 — 0.22; 1.18…
Chronic Non-malignant Pain
Primary: The Number of Subjects With Ineffective Treatment During the Double-blind Evaluation Phase. — 89; 66; 155; 81 participants — p=.0217
Hepatitis B, Chronic · Cirrhosis · Fibrosis
Primary: Number of Participants With Histologic Improvement at Month 36 (Intent-to-Treat Population) — 52 participants
Schizophrenia · Schizoaffective Disorder
Primary: Pharmacokinetic Parameter of Maximum Plasma Concentration (Cmax) of Two Differing Tablet Strengths (3 x 5 mg and 1 x 15 mg) of Sublingually Administered Org 5222…